TOT BIOPHARM International Co. Ltd. (HK:1875) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
TOT BIOPHARM International Co. Ltd. has scheduled a board meeting on August 13, 2024, to review and approve its financial performance for the first half of the year. The announcement, issued by CEO Dr. Liu Jun, underlines the company’s commitment to transparency in its operations and forward planning. This meeting is a key event for stakeholders to gauge the company’s mid-year financial health and strategic direction.
For further insights into HK:1875 stock, check out TipRanks’ Stock Analysis page.